Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.262
-0.023 (-8.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.264
+0.002 (0.76%)
Pre-market: Apr 29, 2026, 8:07 AM EDT
Outlook Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 27 | 47 | 126 | 58 | 276 | 380 | |
| Market Cap Growth | -39.09% | -62.73% | 119.64% | -79.15% | -27.49% | 315.51% | |
| Enterprise Value | 56 | 73 | 127 | 59 | 260 | 372 | |
| Last Close Price | 0.26 | 1.06 | 5.34 | 4.42 | 24.40 | 43.40 | |
| PS Ratio | 133.30 | 33.31 | - | - | - | - | |
| PB Ratio | - | -1.46 | -1.73 | -3.98 | 31.58 | 82.58 | |
| P/TBV Ratio | - | - | - | - | 31.58 | 82.58 | |
| EV/Sales Ratio | 270.46 | 51.56 | - | - | - | - | |
| Debt / Equity Ratio | -0.96 | -0.94 | -0.41 | -2.46 | 1.25 | 2.58 | |
| Net Debt / Equity Ratio | -0.73 | -0.69 | -0.20 | -0.84 | -0.74 | -0.56 | |
| Net Debt / EBITDA Ratio | -0.48 | -0.33 | -0.21 | -0.23 | 0.10 | 0.05 | |
| Net Debt / FCF Ratio | -0.51 | -0.43 | -0.21 | -0.28 | 0.11 | 0.05 | |
| Asset Turnover | 0.01 | 0.06 | - | - | - | - | |
| Quick Ratio | 0.18 | 0.21 | 0.35 | 0.50 | 0.88 | 2.14 | |
| Current Ratio | 0.35 | 0.38 | 0.64 | 0.66 | 1.40 | 3.19 | |
| Return on Equity (ROE) | - | - | - | - | -989.99% | -1430.33% | |
| Return on Assets (ROA) | -209.03% | -176.82% | -146.63% | -109.17% | -153.56% | -151.98% | |
| Return on Capital Employed (ROCE) | 191.30% | 246.30% | 522.20% | 368.10% | -716.90% | -322.10% | |
| Earnings Yield | -375.14% | -132.58% | -59.66% | -102.55% | -23.94% | -13.97% | |
| FCF Yield | -203.51% | -110.08% | -54.46% | -74.72% | -20.54% | -14.26% | |
| Buyback Yield / Dilution | -105.06% | -87.59% | -48.29% | -17.96% | -38.91% | -110.43% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.